A few studies related to endocan have been evaluated in pituitary adenomas [6, 10] and only one study showed expressions of this molecule at both the mRNA and protein levels in human glioma cell lines and used tissue sections from gliomas to determine localization of endocan immunoreactivity in situ [5]. Here, ESM1 is linked to glioma.